Sandip Agarwala Talaris board

Sandip Agarwala

Mr. Agarwala is a Managing Director of Longitude Capital focused on investments in biotechnology and royalties. He currently serves on the boards of Cydan Development, Talaris Therapeutics, Tiburio Therapeutics, and is a board observer of Inozyme Pharma. He also leads CrownWheel Partners, Longitude Capital’s royalty and structured investment strategy. Prior to joining Longitude, Mr. Agarwala was at Auven Therapeutics, a life sciences private equity firm, and was a consultant in the healthcare practice at the Boston Consulting Group. Mr. Agarwala’s professional experience also includes roles at Healthcare Royalty Partners, Paul Capital Partners and The Frankel Group, a boutique healthcare consulting firm. Mr. Agarwala holds an M.B.A. in Finance and Health Care Management from the Wharton School of Business at the University of Pennsylvania and a B.S.E. in Systems Engineering from the University of Pennsylvania